Welireg 40 MG Oral Tablet

RxCUI: 2567237
RxNorm name: Welireg 40 MG Oral Tablet
Display name: Welireg 40 MG Oral Tablet
Full name: Welireg 40 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
WELIREG	BELZUTIFAN	Merck Sharp & Dohme LLC	13e15ee0-d679-4fa9-9430-e2e2170474da	2026-06-12	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2567237

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
13e15ee0-d679-4fa9-9430-e2e2170474da	Welireg 40 MG Oral Tablet [PSN] · belzutifan 40 MG Oral Tablet [Welireg] [SBD] · Welireg 40 MG Oral Tablet [SY]	3	11	These highlights do not include all the information needed to use WELIREG safely and effectively. See full prescribing information for WELIREG. WELIREG ® (belzutifan) tablets, for oral use Initial U.S. Approval: 2021	20250514